Yahoo Web Search

    • 4D Pharma Plc ("4D Pharma") Receives Notice Of Delisting From Nasdaq

      TheStreet.com· 47 minutes ago

      ...leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that on June 27, 2022, it received written notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that in accordance with Listing Rules 5101, 5110(b), and...